Seeking Alpha

ThinkEquity feels Regeneron (REGN +0.4%) will move higher over near-term, saying the Phase I...

ThinkEquity feels Regeneron (REGN +0.4%) will move higher over near-term, saying the Phase I data of its REGN727 for cholesterol management was "impressive." The firm expects its presentation of additional data this weekend to boost the stock further, and reiterates its Buy rating on the shares.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)